From Free Rider to Innovator: The Rise of China's Drug Development
收藏数据链接：
官方服务：
资源简介：
This paper examines Chinas transition from pharmaceutical free rider to global innovator over the last decade. In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the US in annual registered clinical trial volume. To study this transformation, we compile a
提供机构：
美国国家经济研究局创建时间：
2026-03-01
